Now in its 2nd year, this interactive and educational forum is designed for paediatric dietitians, CEW specialist nurses, clinical leads and consultant endocrinologists.
Join your colleagues from child weight-management services to network, hear from expert speakers and take away new resources ready to implement within your teams. Through expert insights, real-world case studies and productive interactive discussions, you will gain the tools, connections and confidence to optimise your pathways, enhance patient experience and improve long-term outcomes for children and families.
Sponsored by: 
Rhythm Pharmaceuticals has provided sponsorship to SBK to cover the cost of stand space for this meeting. Rhythm Pharmaceuticals has had no influence over the meeting agenda or arrangements.
Practical take-home solutions
Strengthen your pathways
With thanks to our sponsors
SBK Healthcare would like to thank Rhythm for sponsoring this forum.
Rhythm Pharmaceuticals has provided sponsorship to SBK to cover the cost of stand space for this meeting. Rhythm Pharmaceuticals has had no influence over the meeting agenda or arrangements.
Invitation to sponsor or exhibit
| 8:30 |
Registration and networking opportunity
|
| 9:00 |
Welcome, introduction and chair’s opening remarks
|
| NHS England update | |
| 9:10 |
Implementing preventative measures and exploring latest guidance in weight-management
|
| Improving engagement | |
| 9:40 |
Embedding strategies to aid children and young people’s engagement with your service
|
| 10:10 |
Questions and answers with your speakers
|
| 10:20 |
Interactive discussion: Facilitating smooth and safe transitions from paediatric to adult weight-management services
|
| 10:35 |
Feedback for interactive discussion: Facilitating smooth and safe transitions from paediatric to adult weight-management services
|
| 10:45 |
Sponsored presentation from Rhythm
|
| 10:55 |
Questions and answers with your sponsor
|
| 11:05 |
Networking lunch
|
| Navigating GLP-1s | |
| 11:25 |
Understanding the implications of GLP-1 use and the impact on your service
Dr Evelien Gevers, Consultant in Paediatric Endocrinology, Diabetes and Honorary Reader in Paediatric Endocrinology, The William Harvey Research Institute, Queen Mary University
|
| Genetics update | |
| 11:55 |
Supporting children and young people with genetic weight-management disorders
Professor Sadaf Farooqi, Professor of Metabolism and Medicine, University of Cambridge
|
| 12:25 |
Questions and answers with your speakers
|
| 12:35 |
Interactive discussion: Supporting patients with neurodivergence in your service
|
| 12:50 |
Feedback on interactive discussion: Supporting patients with neurodivergence in your service
|
| 1:00 |
Networking lunch
|
| Supporting primary care | |
| 2:00 |
Implementing tools to ensure engagement, support and timely referrals from primary care
Dr Omobolanle Kazeem, Consultant Paediatrician, Norfolk and Norwich University Hospitals NHS Foundation Trust
|
| 2:30 |
Questions and answers with your speaker
|
| 2:40 |
Interactive discussion: Maximising engagement and preventing late-stage referrals
|
| 2:55 |
Feedback from interactive discussion: Maximising engagement and preventing late-stage referrals
|
| 3:05 |
Networking break
|
| Psychological wellbeing | |
| 3:25 |
Prioritising the psychological wellbeing of children in your weight-management service
|
| CEW Clinic Efficiency | |
| 3:55 |
Tracking clinical and economic progress and framework development to optimise care in CEW clinics
Dr Catherine Homer, Associate Professor, Sheffield Hallam University, Research Lead on ENHANCE
|
| 4:25 |
Questions and answers with your speakers
|
| 4:35 |
Chair’s closing remarks and close of day
|
Call for speakers
Confirmed speakers
Sadaf Farooqi is a Wellcome Principal Research Fellow and Professor of Metabolism and Medicine at the University of Cambridge, UK. She is an internationally leading Clinician Scientist who has made seminal contributions to understanding the genetic and physiological mechanisms that underlie obesity and its complications. The work of Sadaf Farooqi and her colleagues has fundamentally altered the understanding of how body weight is regulated. With colleagues, she discovered and characterised the first genetic disorders that cause severe childhood obesity and established that the principal driver of obesity in these conditions was a failure of the control of appetite. Her work is often cited as an exemplar of how the translation of research into the mechanisms of disease can lead to patient benefit. She has received a number of awards including the 2024 Outstanding Clinical Investigator Award from the Endocrine Society. In 2021, she was elected as a Fellow of the Royal Society in recognition of her exceptional contribution to science.
Dr Evelien Gevers studied Medicine at Leiden University in Leiden, The Netherlands. She developed her interest in Paediatric Endocrinology as an undergraduate, and studied the effect of GnRH analogue treatment in girls with precocious puberty in the Paediatric Endocrine department in Leiden University Medical Centre. After graduating, she worked for a few months as a clinical scientist in the Dutch Working Group for Growth Hormone, with Prof Jan Maarten Wit. She then won a 2 year grant from the Royal Dutch Academy of Sciences to study growth hormone (GH) secretion, GH binding protein and GH receptors and their regulation by sex steroids in the rat, in The National Institute for Medical Research in Mill Hill, with Prof Iain Robinson. After return to The Netherlands, she continued her PhD project with Jan Maarten Wit in Leiden University, further focusing on the growth plate and growth, extending her work to estrogen receptors, PTH receptors and PTHrP in the growth plate. She then started her Paediatric training in the Erasmus Medical Centre – Sophia Children’s Hospital in Rotterdam, The Netherlands. She interrupted her clinical training to return to Iain Robinson’s group in The National Institute for Medical Research in 1999, as a postdoctoral scientist and worked on the GH deficient dwarf rat, GH and bone marrow adipocytes, and GH signalling through Stat5b in the growth plate. She then also joined the Department of Endocrinology at Great Ormond Street Hospital as an honorary clinical fellow with Prof Mehul Dattani. From 2007, she continued her Paediatric training in London Hospitals, and Paediatric Endocrine training in Great Ormond Street Hospital for Children. In 2012, she worked at the Erasmus Medical Centre – Sophia Children’s Hospital and the diabetes centre ‘Diabeter’ to complete her training for dual Dutch and UK registration and continued there in her first Consultant post. In 2013, she was appointed as a Consultant Paediatric Endocrinologist in Barts Health – Royal London Children’s Hospital with an academic component at the Centre for Endocrinology at WHRI.
She has been awarded Young Investigator Awards from the European Society for Paediatric Endocrinology, the Dutch Society for Paediatrics and the GH and IGF1 Research Society.
She is a member and Vice-Chair of the Science Committee of the European Society for Paediatric Endocrinology, a member of the National Paediatric Diabetes Audit Data Working Group, and the National Working Group for Type 2 Diabetes in Children and the British Paediatric and Adolescent Bone Group.
She is PI for many commercial and non-commercial NIHR studies at Royal London Children’s Hospital and is the National Coordinating Investigator for studies in Prader Willi Syndrome (Destiny, Soleno) and Type 2 Diabetes (Vertis, Merck). She is part of the Oversight Committee for the Interleukin-2 Therapy of Autoimmunity in Diabetes Study.
Dr Catherine Homer is an Associate Professor of Obesity and Public Health in the Physical Activity, Wellness and Public Health research group based in the School of Sport and Physical Activity, Sheffield Hallam University. Catherine is the Healthy and Active 100 research theme lead in the Advanced Wellbeing Research Centre (AWRC), Deputy Editor of the Journal Perspectives in Public Health and the Yorkshire and Humber and the Public Health Specialist Research Lead for the NIHR Research Delivery Network. Catherine an expert in public health and obesity with 20+ years' research and practice experience as a Public Health Specialist in a NHS Trust and Local Authority. Catherine has over 60 peer-reviewed articles and conference proceedings on qualitative health evaluations of paediatric/adolescent obesity, experiences of bariatric surgery, and fuel poverty health risks (old and cold) and on research grants worth over £7.4m as PI/Co-I. Catherine has strong collaborations with external partners and academic institutions and is currently PI on a £1.5m NIHR HS&DR funded (2024-26) project 'ENHANCE - Evaluating the NHS England12 Complications of Excess weight clinics for children and young people' led by academics from five universities and two hospital trusts. Catherine is also Co-I on a £5m NIHR PHR project Doncaster Health Determinants Research Collaboration (2022-2027).
Pricing Struture
Venue details
Terms and Conditions
Expected attendees
Past attendee feedback
“Very well organised, resources to take away were great, and there was plenty of networking opportunities!”
South Tees Hospitals NHS Foundation Trust
“Brilliant day – great speakers highlighting the importance of our CEW clinics, and why we must continue to develop our pathways”
Alder Hey Children’s Hospital Trust
“A great, really well-run event, I thoroughly enjoyed it. There were a good selection of speakers and subjects, and well-delivered talks. It was great to have an opportunity to network with a range of relevant professionals”
University Hospitals Leicester NHS Trust
“I am grateful for all the knowledge, it will positively affect how I conduct consultations going forward”
Worcestershire Acute Hospitals NHS Trust, Foundations of Obesity Management: From First Consultations to Long-Term Support, December 2025
“Very informative and educational, I’ve learnt a lot, and it’s expanded my knowledge”
Imperial College Healthcare NHS Trust, Foundations of Obesity Management: From First Consultations to Long-Term Support, December 2025
“Very informative day which looked at and considered the wider holistic picture of patients living with obesity. Inspiring to be around many like-minded individuals to tackle obesity stigma”
Worcestershire Acute Hospital NHS Trust, Obesity Management National Networking Forum, November 2024
With thanks to our sponsor
Rhythm Pharmaceuticals is a global biopharmaceutical company committed to improving the lives of patients with rare neuroendocrine diseases by developing medicines that address the root cause. For more information, please contact Fleur Taylor at ftaylor@rhythmtx.com . UK-RHY-2500001 I Date of preparation: January 2025.
Rhythm Pharmaceuticals has provided sponsorship to SBK to cover the cost of stand space for this meeting. Rhythm Pharmaceuticals has had no influence over the meeting agenda or arrangements.
Why sponsor?
Your event, managed by us
SBK Healthcare also provides in-house forums. Working closely with you as the client we can research, produce, market and deliver the conference or online forum that best suits the audience and meets your goals.